Psyence Biomedical Ltd. Common Shares (PBM) — Net Asset Momentum
Psyence Biomedical Ltd. Common Shares (PBM) recorded a net asset momentum of 161.3% as of March 2025, with net assets of $6.72 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See what is Psyence Biomedical Ltd. Common Shares's book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Psyence Biomedical Ltd. Common Shares Net Asset Momentum (2021–2025)
This chart tracks Psyence Biomedical Ltd. Common Shares's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is +161.3%, with net assets of $6.72 Million USD as of March 2025. For live market cap and overall valuation, see Psyence Biomedical Ltd. Common Shares stock valuation.
Annual Net Asset History for Psyence Biomedical Ltd. Common Shares (2021–2025)
The table below shows the complete annual net asset history for Psyence Biomedical Ltd. Common Shares from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check how tangible is Psyence Biomedical Ltd. Common Shares's equity to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $6.72 Million | $7.32 Million | $594.37K | ▲ +161.3% |
| 2024 | $-10.97 Million | $1.13 Million | $12.10 Million | ▼ -104.5% |
| 2023 | $244.66 Million | $258.93 Million | $14.27 Million | ▲ +2.0% |
| 2022 | $239.84 Million | $256.22 Million | $16.38 Million | ▲ +4895.9% |
| 2021 | $4.80 Million | $4.90 Million | $101.08K | — |